Myriad and American College of Surgeons collaborate:
This article was originally published in Clinica
Executive Summary
The American College of Surgeons and Myriad Genetic Laboratories are to collaborate on a long-term study into the outcomes of patients undergoing BRCA1 genetic analysis for breast and ovarian cancer susceptibility. The study will aim to discover which BRCA1 mutations are strongly penetrant as well as the likely clinical outcome after medical and surgical intervention.